IP
Ionis Pharmaceuticals Inc
🇺🇸XNAS.IONSUnited StatesHealthcare
$75.56USDdown -0.20 (-0.26%)OpenEnd of day4:15 PM
Price$75.56-0.20 (-0.26%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US4622221004
- CUSIP
- 462222100
Company
- Employees
- 1,480
- Headquarters
- Carlsbad, United States
- Website
- https://www.ionis.com
- CEO
- Dr. Brett P. Monia Ph.D.
Market
- Shares outstanding
- 166.2M
- Market cap
- $12.49B
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $12.49B
- EPS LTM
- -$3.40calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -22.23calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 0.18%calculatedCalculated by Finzer, not reported by the data provider.
Fundamentals (LTM)
- Revenue
- $873.76M-7.45%down year on year
- Net income
- -$564.78M-110.57%down year on year
- Gross margin
- 98.16%-0.73%down year on year
- Free cash flow
- -$558.88M-91.42%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.